SeaStar Medical
Clinical trials sponsored by SeaStar Medical, explained in plain language.
A medical device company developing therapies for critical care, including kidney and inflammatory conditions.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New device aims to save kidneys and lives in the ICU Results expected Dec 2026 (estimated)
- New device aims to bridge heart failure patients to Life-Saving pump Results expected Feb 2027 (estimated)
-
New device for kids with kidney failure under safety watch
Disease control Recruiting nowThis study monitors the safety of QUELIMMUNE, a device already approved for emergency use in critically ill children with acute kidney injury caused by sepsis. Researchers will track 50 patients to see how many develop new bloodstream infections within 28 days. The goal is to ens…
Sponsor: SeaStar Medical • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New device aims to save kidneys and lives in the ICU
Disease control Recruiting nowThis study tests a device called the Selective Cytopheretic Device (SCD) in 339 ICU patients with severe acute kidney injury who are already on continuous kidney replacement therapy. The device filters blood to reduce inflammation, and researchers want to see if it improves survi…
Sponsor: SeaStar Medical • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New device aims to bridge heart failure patients to Life-Saving pump
Disease control Recruiting nowThis study tests a device that filters out overactive immune cells from the blood to reduce inflammation in patients with severe heart failure and worsening kidney function. Twenty ICU patients will receive 4-hour treatments daily for up to 6 days. The goal is to see if it safely…
Sponsor: SeaStar Medical • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC